Cash purchase direct from Inogen, which no longer bills insurance or Medicare; prescription required, and it can be returned within 30 days for a full credit.
From the maker’s page on inogen.com, checked November 17, 2026.
Inogen direct cash price (Rove 4)
Maker’s price from Inogen
For anyone · from$2,995for the Rove 4
Cash purchase direct from Inogen, which no longer bills insurance or Medicare; prescription required, and it can be returned within 30 days for a full credit.
Mobile/portable oxygen concentrator. A mobile/portable mains electricity (AC-powered) device designed to concentrate oxygen (O2) from ambient air and deliver the concentrated O2, typically through an attached nasal cannula, to a patient requiring oxygen therapy. It processes the air through an internal filtration system, e.g., a molecular sieve (zeolite granules or membranes), having a large total surface area to separate nitrogen (N2) from the air. It typically consists of an air compressor, filters, dual chambers, a reservoir and controls. The O2 concentration is variable depending on the flow rate utilized. It is used in a home, institution, or a vehicle and typically has internal batteries for transportable use.
Only your prescriber can say whether a device is right for you.
In the FDA’s device database
Needs a prescription.
Company on its FDA records: Inogen. Its support line: 877-466-4362.
2 versions sold now
Each opens its FDA record. The model number is on the box.
Inogen Rove 4The Inogen Rove 4 Portable Oxygen Concentrator system is used on a prescriptive basis by patients requiring supplemental oxygen. It supplies a high concentration of oxygen and is used with a nasal cannula to channel oxygen from the concentrator to the patient. The Inogen Rove 4 Oxygen Concentrator mModel 10-10417-00-01 (BT)
Inogen Rove 62.1. The Inogen Rove 6 Portable Oxygen Concentrator system is used on a prescriptive basis by patients requiring supplemental oxygen. It supplies a high concentration of oxygen and is used with a nasal cannula to channel oxygen from the concentrator to the patient. The Inogen Rove 6 Oxygen ConcentraModel 10-12017-00-02 (BT)
Source: the FDA’s device database (GUDID), November 2, 2026.